These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 28209634)

  • 21. Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis.
    McGinty HL; Phillips KM; Jim HS; Cessna JM; Asvat Y; Cases MG; Small BJ; Jacobsen PB
    Support Care Cancer; 2014 Aug; 22(8):2271-80. PubMed ID: 24859915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Body image issues and attitudes towards exercise amongst men undergoing androgen deprivation therapy (ADT) following diagnosis of prostate cancer.
    Gentili C; McClean S; Hackshaw-McGeagh L; Bahl A; Persad R; Harcourt D
    Psychooncology; 2019 Aug; 28(8):1647-1653. PubMed ID: 31141623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive and neurobehavioral symptoms in patients with non-metastatic prostate cancer treated with androgen deprivation therapy or observation: A mixed methods study.
    Wu LM; Tanenbaum ML; Dijkers MP; Amidi A; Hall SJ; Penedo FJ; Diefenbach MA
    Soc Sci Med; 2016 May; 156():80-9. PubMed ID: 27019142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer.
    Taaffe DR; Buffart LM; Newton RU; Spry N; Denham J; Joseph D; Lamb D; Chambers SK; Galvão DA
    BJU Int; 2018 Feb; 121(2):194-202. PubMed ID: 28872752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Effect of Exercise on Body Composition and Physical Performance in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy (ADT): A Narrative Synthesis.
    Logan L; Toohey K; Kavanagh PS; Paterson C; McKune AJ
    Semin Oncol Nurs; 2020 Oct; 36(5):151067. PubMed ID: 33010982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nutrition therapy with high intensity interval training to improve prostate cancer-related fatigue in men on androgen deprivation therapy: a study protocol.
    Baguley BJ; Skinner TL; Leveritt MD; Wright OR
    BMC Cancer; 2017 Jan; 17(1):1. PubMed ID: 28049525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protocol for GET FIT Prostate: a randomized, controlled trial of group exercise training for fall prevention and functional improvements during and after treatment for prostate cancer.
    Winters-Stone KM; Li F; Horak F; Dieckmann N; Hung A; Amling C; Beer TM
    Trials; 2021 Nov; 22(1):775. PubMed ID: 34742325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of a Group-Mediated Exercise and Dietary Intervention in the Treatment of Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: Results From the IDEA-P Trial.
    Focht BC; Lucas AR; Grainger E; Simpson C; Fairman CM; Thomas-Ahner JM; Buell J; Monk JP; Mortazavi A; Clinton SK
    Ann Behav Med; 2018 Apr; 52(5):412-428. PubMed ID: 29684136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased risk of metabolic syndrome, diabetes mellitus, and cardiovascular disease in men receiving androgen deprivation therapy for prostate cancer.
    Kintzel PE; Chase SL; Schultz LM; O'Rourke TJ
    Pharmacotherapy; 2008 Dec; 28(12):1511-22. PubMed ID: 19025432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Muscle function, physical performance and body composition changes in men with prostate cancer undergoing androgen deprivation therapy.
    Storer TW; Miciek R; Travison TG
    Asian J Androl; 2012 Mar; 14(2):204-21. PubMed ID: 22367184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer.
    Greenspan SL; Coates P; Sereika SM; Nelson JB; Trump DL; Resnick NM
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6410-7. PubMed ID: 16189261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of clinical effects associated with metabolic syndrome and exercise in prostate cancer patients.
    Kiwata JL; Dorff TB; Schroeder ET; Gross ME; Dieli-Conwright CM
    Prostate Cancer Prostatic Dis; 2016 Dec; 19(4):323-332. PubMed ID: 27349496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of aerobic- and resistance-emphasised exercise on cardiometabolic health and quality of life in men receiving androgen deprivation therapy for prostate cancer: Protocol for a feasibility trial.
    Murphy K; Kehoe B; Denieffe S; Hacking D; Fairman CM; Harrison M
    Contemp Clin Trials; 2024 Jan; 136():107388. PubMed ID: 37972755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgen-deprivation therapy, dementia, and cognitive dysfunction in men with prostate cancer: How much smoke and how much fire?
    McHugh DJ; Root JC; Nelson CJ; Morris MJ
    Cancer; 2018 Apr; 124(7):1326-1334. PubMed ID: 29338083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of androgen deprivation on cerebral morphometry in prostate cancer patients--an exploratory study.
    Chao HH; Hu S; Ide JS; Uchio E; Zhang S; Rose M; Concato J; Li CS
    PLoS One; 2013; 8(8):e72032. PubMed ID: 23977199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computerized cognitive training in prostate cancer patients on androgen deprivation therapy: a pilot study.
    Wu LM; Amidi A; Tanenbaum ML; Winkel G; Gordon WA; Hall SJ; Bovbjerg K; Diefenbach MA
    Support Care Cancer; 2018 Jun; 26(6):1917-1926. PubMed ID: 29282534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Timing of exercise for muscle strength and physical function in men initiating ADT for prostate cancer.
    Newton RU; Galvão DA; Spry N; Joseph D; Chambers SK; Gardiner RA; Hayne D; Taaffe DR
    Prostate Cancer Prostatic Dis; 2020 Sep; 23(3):457-464. PubMed ID: 32020032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical importance of quantifying body fat distribution during androgen deprivation therapy for prostate cancer.
    Foulkes SJ; Daly RM; Fraser SF
    Endocr Relat Cancer; 2017 Mar; 24(3):R35-R48. PubMed ID: 28062546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age and androgen-deprivation therapy on exercise outcomes in men with prostate cancer.
    Alberga AS; Segal RJ; Reid RD; Scott CG; Sigal RJ; Khandwala F; Jaffey J; Wells GA; Kenny GP
    Support Care Cancer; 2012 May; 20(5):971-81. PubMed ID: 21538098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exercise and prostate cancer: From basic science to clinical applications.
    Campos C; Sotomayor P; Jerez D; González J; Schmidt CB; Schmidt K; Banzer W; Godoy AS
    Prostate; 2018 Jun; 78(9):639-645. PubMed ID: 29569731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.